OnDemand WTP Pricing Research

Tag: Health Insurance Pricing

Hospital price rule causes confusion | Rushville Republican

Hospital price rule causes confusion | Rushville Republican

“While mycareINsight is more user friendly than the chargemaster, it still provides charges, which are not what people will pay,” Platt said. “Charges represent a starting point for hospitals contracting with insurers who routinely negotiate discounts from charges on behalf of enrollees.” Platt said the guidelines are a step in the right direction. “I think […]

Lilly, other insulin makers must face price-gouging lawsuit, judge rules | Indianapolis Business Journal

Lilly, other insulin makers must face price-gouging lawsuit, judge rules | Indianapolis Business Journal

Indianapolis-based Eli Lilly and Co. and two other insulin makers must face claims they gouged diabetes patients through deceptive price lists for their life-saving drugs. U.S. District Judge Brian Martinotti in New Jersey on Friday allowed a proposed class-action lawsuit filed by 67 diabetics against Lilly, Novo Nordisk A/S and the U.S. unit of French […]

TV Drug Ads Will Soon Include Prices: Will It Help Consumers? | HealthLine

TV Drug Ads Will Soon Include Prices: Will It Help Consumers? | HealthLine

Prices coming to television The whole purpose of direct-to-consumer (DTC) advertising is to get patients to go to their doctors and inquire about a brand-name drug, which is why most ads’ “action item” is telling you to “talk to your doctor.” DTC is also a practice that’s banned in every country except for the United […]

Letter: Allow drug price negotiations | The Columbian

Letter: Allow drug price negotiations | The Columbian

Current laws have tied the hands of our state medical programs by denying them the right to negotiate medication prices with pharmaceutical manufacturers. We tell them that they will have to take what they can get and deal with the price gouging. So in turn, the state programs have to constantly judge which brand is […]

Commentary: Make drugmakers justify their price increases | HeraldNet

Commentary: Make drugmakers justify their price increases | HeraldNet

At a time when we at Kaiser Permanente are working hard to find efficiencies that bring down costs, our pharmaceutical costs keep going up. In the last two years, prescription drug prices for Kaiser Permanente in Washington have increased by $70 million. The situation is even worse for specialty drugs. These higher-cost, hard-to-manufacture, or hard-to-handle/administer […]

Trump’s free market approach to drug pricing will help lower costs | TheHill

Trump’s free market approach to drug pricing will help lower costs | TheHill

During President Trump’s State of the Union speech, he spoke about the urgent need to lower prescription drug prices. He talked about global freeloading and the injustice of Americans paying more for drugs that are made here than foreign countries do. He discussed the need for price transparency, where drug manufacturers reveal their list prices […]

Fostering Transparency In The Pharmaceutical Market | Forbes

Fostering Transparency In The Pharmaceutical Market | Forbes

In response to the problem of rising list prices for drugs, elected officials continue to propose counterproductive reforms. Whether it is importing drugs from Canada or indexing U.S. drug prices to the prices charged in other countries, these policies will make the current bad situation worse because they fail to understand the disincentives that are […]

Drug pricing reforms will disrupt cancer care for millions | TheHill

Drug pricing reforms will disrupt cancer care for millions | TheHill

From dinner tables to the halls of Congress, the price of prescription drugs has recently dominated conversations across the country. Last year, President Trump unveiled the American Patients First blueprint to reduce the costs of prescription drugs and limit out-of-pocket costs for American consumers. In an effort to address drug costs, President Trump and Health and Human […]

Recent Drug Recall Prompts Possible Price Gouging Attempt | Axcess News

Recent Drug Recall Prompts Possible Price Gouging Attempt | Axcess News

Drug manufacturers Teva Pharmaceutical and Prinston Pharmaceutical were recently forced to recall the important drug valsartan after the Food and Drug Administration determined that the blood pressure medication might contain carcinogens. Drug manufacturer Alembic Pharmaceuticals was not affected by the recall, as its own version of the medication was not found to contain the same […]

Drug Maker Rolls Out a Price Transparency Policy | ThinkAdvisor

Drug Maker Rolls Out a Price Transparency Policy | ThinkAdvisor

Johnson & Johnson appears to have listened to President Donald Trump’s State of the Union Address Tuesday. Trump, in a portion of his speech devoted to health care, called on pharmaceutical companies to reveal “real prices” – presumably a reference to an administration proposal that would require drugmakers to show the full sticker price, or […]